Latest Breaking News On - Cerevel therapeutics holdings inc - Page 13 : comparemela.com

Cerevel Therapeutics (NASDAQ:CERE) Sees Unusually-High Trading Volume

Shares of Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE – Get Free Report) saw strong trading volume on Tuesday . 1,343,879 shares were traded during trading, a decline of 20% from the previous session’s volume of 1,682,243 shares.The stock last traded at $41.20 and had previously closed at $42.57. Wall Street Analysts Forecast Growth A number of […]

United statesRamiro sanchezZurcher kantonalbank zurich cantonalbankScott akaminePiper sandlerTd asset management incCerevel therapeutics holdings incCharles schwab investment management incJefferies financial groupMirae asset global investments coMorgan stanleyJpmorgan chase coCerevel therapeutics holdingsGet free reportCerevel therapeuticsFinancial group

Cerevel Therapeutics (NASDAQ:CERE) Sees Unusually-High Trading Volume

Shares of Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE – Get Free Report) saw strong trading volume on Tuesday . 1,343,879 shares were traded during trading, a decline of 20% from the previous session’s volume of 1,682,243 shares.The stock last traded at $41.20 and had previously closed at $42.57. Wall Street Analysts Forecast Growth A number of […]

United statesPiper sandlerScott akamineZurcher kantonalbank zurich cantonalbankRamiro sanchezMorgan stanleyJpmorgan chase coTd asset management incCharles schwab investment management incCerevel therapeutics holdings incJefferies financial groupMirae asset global investments coCerevel therapeutics holdingsGet free reportCerevel therapeuticsFinancial group

AbbVie taps new CEO as it faces fresh competition for blockbuster drug Humira

AbbVie taps new CEO as it faces fresh competition for blockbuster drug Humira
marketwatch.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketwatch.com Daily Mail and Mail on Sunday newspapers.

Glenn tiltonRichard gonzalezRobert michaelCerevel therapeutics holdings incAbbvie incCerevel therapeutics holdings

Mental health stocks: Innovation and M&A to boost these stocks

Two recent M&A announcements by big pharma are creating excitement among investors. Here's who is poised to benefit.

United statesDeloitte miccaKen duckworthBlair minterRichard closeNeurocrine biosciencesCanaccord genuityMyles minterMackenzie scottMarc goodmanTema etfsBristol myers squibbPeter miccaWilliam blairKaruna cerevelAshwani verma

This Analyst Is Bullish On Biohaven s Approach in Neuro-Psych Space - Biohaven (NYSE:BHVN)

Biohaven's potential with RBC Capital Markets' optimistic outlook.. RBC sees blockbuster potential of $3.2 billion across epilepsy and mood disorders. Anticipate significant developments in lead asset Kv7-7000's Phase 3 trial this year, reducing late-stage risks.

Biohaven ltdCerevel therapeutics holdings incKaruna therapeutics incXenon pharmaceuticals incXenon pharmaceuticalsSpeculative risk